Paper · 2025 · IOP Conference Series Earth and Environmental Science

Impact of Jasmonic Acid and Selected Grow Regulators on the in Vitro Biosynthesis of Secondary Metabolic Products in Phoenix dactylifera L. cv. Barhi Assessed by GC-MS

H S Albushmainah; L S Al-Rekaby; A J Musa

4
claims
9
verbatim quotes
1
citations
2
research areas
✓
Open access · cc-by

Abstract

Abstract This study aimed to evaluate effect of jasmonic acid (JA), and selected growth regulators on the in vitro biosynthesis of secondary metabolites in plant callus cultures of Phoenix dactylifera L . cv. Barhi. Gas Chromatography-Mass Spectrometry (GC-MS) detected and examined secondary metabolites. Callus tissues were cultured on MS medium supplemented with different combinations of JA, 2iP, 2,4-D, NAA. The metabolic profiling revealed that Treatment B (2 JA, 2 2iP, 8 2,4 -D, 40 NAA) mg/L produced the highest diversity and total number of secondary metabolites, identifying 50 compounds with 66% being unique metabolites. In contrast, Treatment F (4 JA, 4 2iP, 12 2,4 -D, 60 NAA) mg/L achieved the highest ratio of unique metabolites (77.5%) but resulted in a lower total number of identified compounds (40 metabolites). These findings suggest that using moderate concentrations of plant growth regulators (PGR) more effectively enhances the diversity and accumulation of secondary metabolites compared to higher concentrations. The findings highlight the potential of tailoring growth regulator combinations as an effective technique for increasing bioactive chemical production in plant tissue culture systems for pharmaceutical and commercial use.

Abstract from the paper’s OpenAlex record; open copy licensed cc-by. Read at the source ↗

The text the model read, with the source record’s inline markup (italics, sub- and superscripts) rendered and its character entities decoded; quote offsets refer to the raw text.

Claims 4

Intervention effectobservedoriginal resultpositivemeasured

Claim · model-written summary

Treatment B produced the highest diversity and total number of secondary metabolites, identifying 50 compounds.

Taxon
Phoenix dactylifera L. cv. BarhiPhoenix dactyliferat0
Organ / stage
Calluse1
Treatment
Treatment B (2 JA, 2 2iP, 8 2,4 -D, 40 NAA) mg/Le0
Outcome
diversity and total number of secondary metabolitese0
Direction
higheste0
Value
50 compoundse0

Not reportedComparator

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Phoenix dactylifera
Phoenix dactylifera · TaxonEJ Burns · CC BY 4.0 · Wikimedia Commons ↗

Verbatim

t0

“Phoenix dactylifera L. cv. Barhi”

✓ located verbatim in the source · title, characters 117–149 · show in text ↑
e0

“Treatment B (2 JA, 2 2iP, 8 2,4 -D, 40 NAA) mg/L produced the highest diversity and total number of secondary metabolites, identifying 50 compounds with 66% being unique metabolites”

✓ located verbatim in the source · abstract, characters 451–632 · show in text ↑
e1

“Callus tissues were cultured”

✓ located verbatim in the source · abstract, characters 306–334 · show in text ↑
Observationobservedoriginal resultpositivemeasured

Claim · model-written summary

Treatment B metabolites were 66% unique.

Taxon
Phoenix dactylifera L. cv. BarhiPhoenix dactyliferat0
Treatment
Treatment Be0
Outcome
unique metabolitese0
Value
66%e0

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Phoenix dactylifera
Phoenix dactylifera · TaxonEJ Burns · CC BY 4.0 · Wikimedia Commons ↗

Verbatim

t0

“Phoenix dactylifera L. cv. Barhi”

✓ located verbatim in the source · title, characters 117–149 · show in text ↑
e0

“Treatment B (2 JA, 2 2iP, 8 2,4 -D, 40 NAA) mg/L produced the highest diversity and total number of secondary metabolites, identifying 50 compounds with 66% being unique metabolites”

✓ located verbatim in the source · abstract, characters 451–632 · show in text ↑
Intervention effectobservedoriginal resultpositivemeasured

Claim · model-written summary

Treatment F achieved the highest unique metabolite ratio of 77.5%.

Taxon
Phoenix dactylifera L. cv. BarhiPhoenix dactyliferat0
Treatment
Treatment F (4 JA, 4 2iP, 12 2,4 -D, 60 NAA) mg/Le0
Outcome
ratio of unique metabolitese0
Direction
higheste0
Value
77.5%e0

Not reportedComparator

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Phoenix dactylifera
Phoenix dactylifera · TaxonEJ Burns · CC BY 4.0 · Wikimedia Commons ↗

Verbatim

t0

“Phoenix dactylifera L. cv. Barhi”

✓ located verbatim in the source · title, characters 117–149 · show in text ↑
e0

“Treatment F (4 JA, 4 2iP, 12 2,4 -D, 60 NAA) mg/L achieved the highest ratio of unique metabolites (77.5%)”

✓ located verbatim in the source · abstract, characters 647–753 · show in text ↑
Intervention effectobservedoriginal resultpositivemeasured

Claim · model-written summary

Treatment F yielded a lower total of 40 identified metabolites.

Taxon
Phoenix dactylifera L. cv. BarhiPhoenix dactyliferat0
Treatment
Treatment F (4 JA, 4 2iP, 12 2,4 -D, 60 NAA) mg/Le0
Outcome
total number of identified compoundse0
Direction
lowere0
Value
40 metabolitese0

Not reportedComparator

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Phoenix dactylifera
Phoenix dactylifera · TaxonEJ Burns · CC BY 4.0 · Wikimedia Commons ↗

Verbatim

t0

“Phoenix dactylifera L. cv. Barhi”

✓ located verbatim in the source · title, characters 117–149 · show in text ↑
e0

“Treatment F (4 JA, 4 2iP, 12 2,4 -D, 60 NAA) mg/L achieved the highest ratio of unique metabolites (77.5%) but resulted in a lower total number of identified compounds (40 metabolites)”

✓ located verbatim in the source · abstract, characters 647–831 · show in text ↑

2,4-D · molecular: metabolites · Phoenix dactylifera (date palm)Results agree

2 papers: 2 positive, 0 negative or no effect

1 paper in the same direction as this paper

  1. positive
See all 2 papers →

2,4-D · quality: phytochemicals · Phoenix dactylifera (date palm)Results agree

3 papers: 3 positive, 0 negative or no effect

2 papers in the same direction as this paper

  1. positive
  2. positive
See all 3 papers →

Claims are grouped by organism, treatment and what was measured or targeted. A paper counts as positive when any of its claims in the group is positive.